Despite the obesity-dependent effects of cilostazol on PCSK9 expression, we observed similar effects on the expression of AMPKα and PPARγ, suggesting that mechanisms beyond AMPK/PPARγ activation may be at play. Here, PCSK9 is linked to obesity disorder.